Skip to main content
Book Chapter

Imatinib Mesylate (Gleevec®) and the Emergence of Chemotherapeuticss Drug-Resistant Mutations

  • Denis G
Humana Press, (2007), 545-558
DOI: 10.1007/978-1-59745-337-0_22
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Denis, G. V. (2007). Imatinib Mesylate (Gleevec®) and the Emergence of Chemotherapeuticss Drug-Resistant Mutations. In Molecular Targeting in Oncology (pp. 545–558). Humana Press. https://doi.org/10.1007/978-1-59745-337-0_22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free